Library of Pharmacologically Active Compounds (LOP
Closed Solicitation Posted
- Solicitation number
- 75N98026Q00991
- Agency
-
Office of Logisitics and Acquisition Operations
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institutes of Health, Office of Logistics and Acquisition Operations, seeks a firm-fixed-price contract to conduct a Broad Institute pooled cancer cell line drug sensitivity study (PRISM platform) evaluating compound NCGC01219867 against approximately 900 barcoded cancer cell lines, with quotations due August 24, 2026 at 8:00 AM EST. This is an unrestricted, full and open competition under FAR 12.603 for commercial products or services.
The contract period runs September 4, 2026 through December 3, 2026, with data delivery approximately four months after the submission window closes. The contractor must conduct a five-day assay using Luminex-format screening at eight-point dose with threefold dilution, with compounds submitted as 1000x stock concentration in 100% DMSO. Deliverables include data detailing cell line viability, assay quality metrics, univariate and multivariate correlation analysis, and raw data reported through the PRISM Portal. The government provides the compound analog; the contractor furnishes all personnel, equipment, and facilities. All data becomes sole property of the government and NCATS.
The NAICS code is 325412, Pharmaceutical Preparation Manufacturing, with a small business size standard of 1,300 employees. Required submission elements include unit and total pricing, shipping and handling costs, delivery timeframe, F.O.B. point, product descriptions, Unique Entity Identifier, Taxpayer Identification Number, and SAM.gov registration. Evaluation factors include price, technical capability, past performance, and delivery schedule. Contact Jaddua Johnston, Contracting Specialist, 240-569-0006, Jaddua.Johnston@nih.gov.
Notice text
(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes only solicitation; proposals are being requested, and a separate written solicitation will not be issued.
(ii) The solicitation number is 75N98026Q00991. This solicitation is issued as a competitive combined synopsis/solicitation for commercial products or commercial services. The Government intends to award a contract or purchase order resulting from this solicitation using full and open competition.
This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and is not expected to exceed the simplified acquisition threshold (if applicable).
The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, seeks to award a (Firm-Fixed-Price) to the offeror responsible whose proposal represents the best value to the Government.
(iii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular effective August 7, 2026
(iv) The associated NAICS code is 325412 Pharmaceutical Preparation Manufacturing and the small business size standard is 1300 employees.
This requirement is unrestricted.
Files
| File | Type | Posted |
|---|---|---|
| Sol_75N98026Q00991.pdf |
Similar open opportunities
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity